Professor Laurence Albiges has been Director of Clinical Research at Gustave Roussy since September 2026. 

A medical oncologist specializing in genitourinary oncology and a professor at Paris-Saclay University, she devotes most of her clinical and scientific work to kidney cancers. Internationally recognized as one of the leading experts in this field, she contributes to the development of new therapeutic strategies and coordinates numerous clinical and translational research programs funded by French and European academic grants. She is the author or co-author of more than 380 scientific publications and, since 2023, has been ranked among the world’s most influential researchers with the Highly Cited Researcher distinction awarded by Clarivate.

At Gustave Roussy, she chaired the Genitourinary Oncology Committee from 2015 to 2021. After serving as deputy head of the Department of Medical Oncology for two years—notably during the COVID-19 pandemic— she was appointed head of the Department of Medical Oncology in October 2021, before taking over as director of Clinical Research in 2026.

Deeply committed to medical education, she is a member of the Scientific Council of the Faculty of Medicine at Paris-Saclay University and is responsible for teaching oncology in the graduate medical program. In 2015, she established the inter-university diploma in genitourinary oncology, which has become a benchmark training program at the national and European levels for oncologists, urologists, and radiation oncologists.

Internationally, she has served on expert panels on kidney cancer for the European Society for Medical Oncology (ESMO) and the European Association of Urology (EAU). She coordinated the ESMO Faculty dedicated to genitourinary tumors other than prostate cancer from 2020 to 2024 and has served on the ESMO European RCC panel since 2018, where she is the lead author of the clinical practice guidelines. She is also a member of the steering committee of Unicancer’s Urogenital Tumors Study Group (GETUG).